W. O'Riordan

531 total citations
8 papers, 434 citations indexed

About

W. O'Riordan is a scholar working on Infectious Diseases, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W. O'Riordan has authored 8 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W. O'Riordan's work include Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Streptococcal Infections and Treatments (3 papers). W. O'Riordan is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Streptococcal Infections and Treatments (3 papers). W. O'Riordan collaborates with scholars based in United States, Lithuania and Argentina. W. O'Riordan's co-authors include Žilvinas Endzinas, Dainis Krieviņš, Mitchell J. Frederick, Elyse Seltzer, David Krause, G. Ralph Corey, Martín E. Stryjewski, Steven L. Barriere, Lala M. Dunbar and Vivian H. Chu and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

W. O'Riordan

8 papers receiving 414 citations

Peers

W. O'Riordan
Samantha Good United States
Gregory E. Steinkraus United States
Sinikka Green United States
Giorgio Mosconi Italy
Rienk Pypstra United States
Sara Yankelev United States
Kimberly Leuthner United States
Ashwin Porwal India
Monica Ghitan United States
Marina Macedo-Viñas Switzerland
Samantha Good United States
W. O'Riordan
Citations per year, relative to W. O'Riordan W. O'Riordan (= 1×) peers Samantha Good

Countries citing papers authored by W. O'Riordan

Since Specialization
Citations

This map shows the geographic impact of W. O'Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. O'Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. O'Riordan more than expected).

Fields of papers citing papers by W. O'Riordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. O'Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. O'Riordan. The network helps show where W. O'Riordan may publish in the future.

Co-authorship network of co-authors of W. O'Riordan

This figure shows the co-authorship network connecting the top 25 collaborators of W. O'Riordan. A scholar is included among the top collaborators of W. O'Riordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. O'Riordan. W. O'Riordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Adams, David, Alejandra González‐Duarte, W. O'Riordan, et al.. (2016). Burden of Illness for Patients with Hereditary Attr Amyloidosis with Polyneuropathy Begins with Symptom Onset and Increases with Disease Progression. Value in Health. 19(7). A436–A436. 3 indexed citations
2.
Corey, Ralph, et al.. (2014). 685Time to Onset and Duration of Adverse Events in Patients with Acute Bacterial Skin and Skin Structure Infections Treated with Oritavancin – The SOLO Studies. Open Forum Infectious Diseases. 1(suppl_1). S194–S194. 1 indexed citations
3.
O'Riordan, W., et al.. (2013). Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary. Clinical Infectious Diseases. 58(suppl 1). S43–S50. 13 indexed citations
4.
Stryjewski, Martín E., Steven L. Barriere, W. O'Riordan, et al.. (2012). Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy. 67(6). 1496–1502. 19 indexed citations
5.
Corey, G. Ralph, et al.. (2007). P845 ATLAS 1: the first Phase 3 study evaluating the new lipoglycopeptide, telavancin, for the treatment of patients with complicated skin and skin structure infections. International Journal of Antimicrobial Agents. 29. S216–S217. 3 indexed citations
6.
Stryjewski, Martín E., W. O'Riordan, William K. Lau, et al.. (2005). Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria. Clinical Infectious Diseases. 40(11). 1601–1607. 146 indexed citations
7.
Seltzer, Elyse, Dainis Krieviņš, Mitchell J. Frederick, et al.. (2005). Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections. Clinical Infectious Diseases. 41(10). 1407–1415. 248 indexed citations
8.
O'Riordan, W. & Neil J. Sherman. (1975). Foreign bodies inhaled by children. Journal of the American College of Emergency Physicians. 4(1). 51–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Good Breakdown of academic impact, for papers by Gregory E. Steinkraus Breakdown of academic impact, for papers by Sinikka Green Breakdown of academic impact, for papers by Giorgio Mosconi Breakdown of academic impact, for papers by Rienk Pypstra Breakdown of academic impact, for papers by Sara Yankelev Breakdown of academic impact, for papers by Kimberly Leuthner Breakdown of academic impact, for papers by Ashwin Porwal Breakdown of academic impact, for papers by Monica Ghitan Breakdown of academic impact, for papers by Marina Macedo-Viñas
Rankless by CCL
2026